Daratumumab and hyaluronidase-fihj, a monotherapy for high-risk smoldering multiple myeloma: a shift in preventing active myeloma?

Bartosz Puła, Wiktoria Ryżewska, Artur Handziuk, Agata Tyczyńska, Tadeusz Kubicki

Open source

DOI: 10.1080/17474086.2026.2715442
Published: 2026-08-10
Container: Expert Review of Hematology
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/17474086.2026.2715442,
  title = {Daratumumab and hyaluronidase-fihj, a monotherapy for high-risk smoldering multiple myeloma: a shift in preventing active myeloma?},
  author = {Bartosz Puła and Wiktoria Ryżewska and Artur Handziuk and Agata Tyczyńska and Tadeusz Kubicki},
  year = {2026},
  journal = {Expert Review of Hematology},
  doi = {10.1080/17474086.2026.2715442},
  url = {https://doi.org/10.1080/17474086.2026.2715442}
}

RIS

TY  - JOUR
TI  - Daratumumab and hyaluronidase-fihj, a monotherapy for high-risk smoldering multiple myeloma: a shift in preventing active myeloma?
AU  - Bartosz Puła
AU  - Wiktoria Ryżewska
AU  - Artur Handziuk
AU  - Agata Tyczyńska
AU  - Tadeusz Kubicki
PY  - 2026
JO  - Expert Review of Hematology
DO  - 10.1080/17474086.2026.2715442
UR  - https://doi.org/10.1080/17474086.2026.2715442
ER  -

APA

Puła, B., Ryżewska, W., Handziuk, A., Tyczyńska, A., & Kubicki, T. (2026). Daratumumab and hyaluronidase-fihj, a monotherapy for high-risk smoldering multiple myeloma: a shift in preventing active myeloma?. Expert Review of Hematology. https://doi.org/10.1080/17474086.2026.2715442

Source records

crossref · retrieved 2026-09-26T01:26:19.647Z